COVID-19 Service Update 8 July 2020 - CardioScan Australia
Free Trial

COVID-19 Service Update 8 July 2020

July 8, 2020

CardioScan customers will remain unaffected by Victoria re-entering stage 3 lockdowns in the face of increasing coronavirus cases.

Despite our Melbourne-based head office location, our core technology along with renewed remote servicing capabilities established under previous COVID-19 restrictions, provides for full continuation of our cardiac analysis and reporting services.

New flexible service options can be provided for clinics looking to ensure continuity of care to vulnerable and self-isolating patients. Please contact your account managers if you’d like to discuss how we can help.

During this period, we will continue to undertake all necessary precautions and additional hygiene measures, and follow the relevant government advice to ensure the health and wellbeing of our customers and staff.

If you have any other questions or concerns, please contact your account manager or CardioScan representative, and we will continue to keep you updated should anything change.

16 March update

As you will be aware, the rapid escalation of events around COVID-19 is impacting us all.

CardioScan is working to adapt to these events as quickly as we can to prevent any impact on our ability to deliver our analysis and reporting services. As an essential service, we believe it’s crucial to continue to support all of our customers including collection centres, hospitals, clinics and doctors. As such, we’ve set contingency plans in place for all our subsidiaries.

Our offices currently remain open with services unaffected. Should we need to close our offices, our cloud technology means we aren’t reliant on any single location or facility.

Our technology has been cloud deployed for five years, so we are established globally to continue to provide services, with our cardiac technicians located in three different countries, and our cardiologists already largely working remotely.

We do not foresee an impact on our ability to provide our analysis and reporting services to the level you expect. However, there may be an impact on repairs and maintenance and potentially on turnaround times. We will advise you if we expect an impact to occur.

We will continue to monitor the situation and manage services in line with government advice and/or requirements in each country of operation.

If you have any concerns or further questions, please contact your account manager or CardioScan representative. We will continue to be in touch as more information is available.

View more
Article Clinical cases News